Results 191 to 200 of about 150,306 (248)
Artificial Intelligence as a Diagnostic Tool for Benign Prostatic Hyperplasia (BPH): A Narrative Review. [PDF]
Aljazei E.
europepmc +1 more source
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Predictors of durability of the prostatic urethral lift (PUL) for benign prostatic hyperplasia. [PDF]
Eure G +5 more
europepmc +1 more source
ABSTRACT Gold has been used for centuries in both ornamental and medicinal contexts. More recently, gold compounds, containing ions or nanoparticles, have attracted attention for their anti‐inflammatory, anticancer, and diagnostic applications. Therefore, concerns about systemic toxicity and biodistribution have prompted investigations into the ...
Samira Maghraoui +2 more
wiley +1 more source
Elevated Estradiol and DHT Levels in the Prostatic Stroma as Key Drivers of Benign Prostatic Hyperplasia Pathogenesis. [PDF]
Pejčić T +10 more
europepmc +1 more source
Single-port extraperitoneal robot-assisted simple prostatectomy for benign prostatic hyperplasia: Surgical technique and initial clinical experience. [PDF]
Hemal S +6 more
europepmc +1 more source
The combination of velocity‐compensated diffusion encoding, spiral readout and strong gradients enabled high‐quality prostate IVIM imaging, offering a promising framework for the development of reliable IVIM‐based biomarkers for prostate cancer detection, characterisation and monitoring.
Malwina Molendowska +6 more
wiley +1 more source
Abstract Benign prostatic hyperplasia (BPH) is the most common urologic disease in aging men, resulting in significant morbidity. The etiologies of BPH are unknown, though chronic prostatic inflammation is known to promote hyperplasia, fibrotic remodeling, and therapeutic resistance in BPH.
Nadia A Lanman +12 more
wiley +1 more source
Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia. [PDF]
Limkar AR, McVary KT, Ricke WA, Lee MS.
europepmc +1 more source

